Saturday, October 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Market Analysts Maintain Bullish Outlook on Terex Despite Recent Share Price Dip

Dieter Jaworski by Dieter Jaworski
September 2, 2025
in Analysis, Earnings, Industrial
0
Terex Stock
0
SHARES
183
VIEWS
Share on FacebookShare on Twitter

Terex Corporation delivered a robust second-quarter 2025 performance, surpassing analyst projections and reaffirming its full-year guidance. This strong operational showing presents a curious contrast to the recent softness observed in the company’s share price.

Exceeding Expectations Amid Market Challenges

The machinery manufacturer reported impressive financial results for the quarter. Revenue climbed to $1.49 billion, significantly exceeding the $1.46 billion forecast and representing a substantial 7.6% increase compared to the same period last year. On the earnings front, Terex posted adjusted earnings per share of $1.49, beating analyst estimates by $0.05.

A key driver of this outperformance was the company’s strategic focus on diversification. The Environmental Solutions Group (ESG), acquired in October 2024, delivered exceptional results that completely offset softer performance in the Aerials business segment. This acquisition is increasingly demonstrating its value as a strategic growth engine for the corporation.

Financial Community Expresses Confidence

Market experts have responded positively to these results. Investment firm Goldman Sachs upgraded its rating on Terex shares from “Neutral” to “Buy” back in May. More recently, UBS Group raised its price target to $52, while Evercore ISI maintains an even more optimistic outlook with a $62 target. The consensus price target among analysts stands at $51.44, suggesting significant potential upside from current trading levels.

Should investors sell immediately? Or is it worth buying Terex?

The recent 4.2% price correction to $49.94 (as of August 29) appears to represent a temporary consolidation phase following strong quarterly results rather than a fundamental concern. When viewed over a one-month horizon, the stock has declined just 1%, and it actually gained 2% over the past week.

Shareholder Returns and Forward Guidance

Management has demonstrated confidence in the company’s financial health through concrete actions. Terex has authorized a new $150 million share repurchase program while maintaining its dividend distribution for the fifth consecutive year. Shareholders will receive a quarterly dividend payment of $0.17 per share.

The leadership team has reaffirmed its full-year outlook, expecting adjusted earnings per share in the range of $4.70 to $5.10 on revenue between $5.3 billion and $5.5 billion. This maintained guidance during uncertain market conditions underscores the company’s operational resilience and stable financial footing.

Market observers now await the third-quarter results scheduled for release in late October, which will indicate whether the recent price adjustment presented a buying opportunity for investors.

Ad

Terex Stock: Buy or Sell?! New Terex Analysis from October 18 delivers the answer:

The latest Terex figures speak for themselves: Urgent action needed for Terex investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 18.

Terex: Buy or sell? Read more here...

Tags: Terex
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Abeona Therapeut. Stock
Analysis

Biotech Firm Abeona Therapeutics Positioned for Significant Growth

October 18, 2025
Rocket Lab USA Stock
Analysis

Institutional Investors Flock to Rocket Lab as Space Sector Soars

October 18, 2025
Unitedhealth Stock
Analysis

Wall Street’s Stark Divide Over UnitedHealth Shares

October 18, 2025
Next Post
MYR Stock

MYR Shares Post Record Results Despite Recent Pullback

PennantPark Floating Rate Capital Stock

PennantPark Maintains Dividend Payout Despite Quarterly Earnings Shortfall

Clene Stock

A Pivotal Year for Clene's Neurological Treatment Pipeline

Recommended

Formycon Stock

Formycon Stock: Q2 Slump Sparks Investor Skepticism

2 months ago
HIMS stock news

Ohio-based Institutional Investor Strs Ohio Decreases Stake in Hims & Hers Health, Inc.

2 years ago
Finance_ Chart up

Analyst Sarah James Bullish on DocGo with 11 Price Target

2 years ago
Exxon Mobil Stock

Can Exxon Mobil Navigate the Oil Price Downturn?

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Wall Street’s Stark Divide Over UnitedHealth Shares

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

Intel’s High-Stakes Transformation: Workforce Cuts and Price Hikes Signal Critical Juncture

LeonardoADR Shares Gain Momentum Ahead of Earnings Report

Enterprise Networking Specialist Gains AI-Driven Market Leadership

Autoliv’s Q3 2025 Results: A Critical Test for Investors

Trending

Robinhood Stock
Crypto Stocks

Robinhood Shares Experience Dramatic Trading Session

by Dieter Jaworski
October 18, 2025
0

Friday's trading session delivered a rollercoaster performance for Robinhood Markets, with the stock undergoing a remarkable transformation...

Abeona Therapeut. Stock

Biotech Firm Abeona Therapeutics Positioned for Significant Growth

October 18, 2025
Rocket Lab USA Stock

Institutional Investors Flock to Rocket Lab as Space Sector Soars

October 18, 2025
Unitedhealth Stock

Wall Street’s Stark Divide Over UnitedHealth Shares

October 18, 2025
Eli Lilly and Stock

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

October 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Robinhood Shares Experience Dramatic Trading Session
  • Biotech Firm Abeona Therapeutics Positioned for Significant Growth
  • Institutional Investors Flock to Rocket Lab as Space Sector Soars

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com